These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6721985)
81. The disposition of diphenhydramine and four of its analogues in rabbits and implication for structure-activity relationship studies in drug design. Parry R; Calvert RT Biopharm Drug Dispos; 1982; 3(3):255-65. PubMed ID: 7139065 [TBL] [Abstract][Full Text] [Related]
82. Prednisolone pharmacokinetics in relation to dose. Rose JQ; Jusko WJ; Nickelsen JA; Green OC J Pediatr; 1979 Jun; 94(6):1014-5. PubMed ID: 448518 [No Abstract] [Full Text] [Related]
83. Effect of surgical operation on the plasma clearance of infused prednisolone. CAMPBELL DW; MARKS LJ; KARGER R Ann Surg; 1960 Jul; 152(1):22-8. PubMed ID: 13807241 [No Abstract] [Full Text] [Related]
84. Sex-based differences in the response to dexamethasone in bacterial meningitis: Analysis of the European dexamethasone in adulthood bacterial meningitis study. Dias SP; Brouwer MC; van de Beek D Br J Clin Pharmacol; 2020 Feb; 86(2):386-391. PubMed ID: 31692016 [TBL] [Abstract][Full Text] [Related]
85. Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS. Ghareeb M; Akhlaghi F Bioanalysis; 2015; 7(8):1037-58. PubMed ID: 25966013 [TBL] [Abstract][Full Text] [Related]
86. Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation. Bergmann TK; Barraclough KA; Lee KJ; Staatz CE Clin Pharmacokinet; 2012 Nov; 51(11):711-41. PubMed ID: 23018468 [TBL] [Abstract][Full Text] [Related]
87. Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients. Barraclough KA; Isbel NM; McWhinney BC; Ungerer JP; Medley G; Johnson DW; Hawley CM; Leary DR; Campbell SB; Staatz CE Eur J Clin Pharmacol; 2011 Dec; 67(12):1243-52. PubMed ID: 21656211 [TBL] [Abstract][Full Text] [Related]
88. Gender aspects of treatment and drug related toxicity in medical oncology. Marosi C Wien Med Wochenschr; 2006 Oct; 156(19-20):534-40. PubMed ID: 17103290 [TBL] [Abstract][Full Text] [Related]
89. Pharmacokinetic considerations in the treatment of inflammatory bowel disease. Schwab M; Klotz U Clin Pharmacokinet; 2001; 40(10):723-51. PubMed ID: 11707060 [TBL] [Abstract][Full Text] [Related]
90. Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race. Magee MH; Blum RA; Lates CD; Jusko WJ J Clin Pharmacol; 2001 Nov; 41(11):1180-94. PubMed ID: 11697751 [TBL] [Abstract][Full Text] [Related]
91. Gender differences in pharmacokinetics. Gleiter CH; Gundert-Remy U Eur J Drug Metab Pharmacokinet; 1996; 21(2):123-8. PubMed ID: 8839685 [TBL] [Abstract][Full Text] [Related]
97. Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man. Edsbäcker S; Andersson KE; Ryrfeldt A Eur J Clin Pharmacol; 1985; 29(4):477-81. PubMed ID: 3912192 [TBL] [Abstract][Full Text] [Related]
98. Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis. Arnold M; Schrieber L; Brooks P Drugs; 1988 Sep; 36(3):340-63. PubMed ID: 3056693 [TBL] [Abstract][Full Text] [Related]